STOKE THERAP (STOK)
$7.71
0.03 (0.39%)
STOK Stock Quote Delayed 30 Minutes
STOK Stock Earnings: Stoke Therapeutics Beats EPS, Beats Revenue for Q1 2024
STOK stock results show that Stoke Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$8.29
Market Cap
448.30M
PE Ratio
-4.68
EPS
-1.6487
Volume (Avg. Vol.)
1.05M
Day's Range
$7.52 - $8.34
52-Week Range
$7.31 - $17.58
Dividend & Yield
N/A (N/A)
